-
Academician Xiaojun Huang: Conquering Leukemia with the Beijing Protocol
Huang Xiaojun, an expert in hematologic diseases, serves as the director of the Hematology Department at Peking University People’s Hospital and the head of the Hematology Disease Research Institute at…
-
Assessment of Mortality-Related Risk Factors and Effective Antimicrobial Regimens for Treatment of Bloodstream Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa in Patients with Hematological Diseases
In May 2023, a study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——Frontiers in Cellular and Infection Microbiology. The title of the study is “Assessment of mortality-related risk factors and effective antimicrobial regimens…
-
Combatting Carbapenem-Resistant Enterobacteriaceae Bloodstream Infections in Neutropenic Pediatric Hematology Patients: A Comprehensive Analysis
In July 2023, a study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal——Antimicrobial Resistance and Infection Control. The title of the study is “High risk of bloodstream infection of carbapenem-resistant enterobacteriaceae carriers in neutropenic…
-
Measurable Residual Disease in Leukemia: Improving Qualification through MRDworst case
In November 2023, a study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal——Leukemia（11.4）. The title of the study is “Have we been qualifying measurable residual disease correctly?”. The comparative analysis between MRDworst case and…
-
Advancing Prognostic Assessment in Pediatric Acute Myeloid Leukemia with KMT2A Rearrangement: Integrating Transcriptomic Profiling
In November 2023, a study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——Hemasphere. The title of the study is “Integration of Transcriptomic Features to Improve Prognosis Prediction of Pediatric Acute Myeloid Leukemia With…
-
Establishment of a Prognostic Model and Tumor Clustering for Pediatric Acute Myeloid Leukemia Patients: Leveraging the Fanconi Anemia Signaling Pathway to Enhance Clinical Management
In November 2023, a study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——Open Medicine(Wars). The title of the study is “Establishing a novel Fanconi anemia signaling pathway-associated prognostic model and tumor clustering for…
-
Long-Term Outcome of Rabbit Anti-Thymocyte Globulin and Cyclosporine Therapy for Pediatric Severe Aplastic Anemia
In May 2023, a study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——Blood Science. The title of the study is “An investigation of long-term outcome of rabbit anti-thymocyte globulin and cyclosporine therapy for…
-
Acinetobacter spp. Bloodstream Infection in Hematological Patients: A 10-Year Single-Center Study
In November 2023, a study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——BMC Infectious Diseases. The title of the study is “Acinetobacter spp. Bloodstream Infection in Hematological Patients: A 10-Year Single-Center Study”. This…
Connecting Medical Expertise through Media